Clinical trial Recruiting at 1 site Observational Ages 18 to 45

Continuous glucose monitoring in PCOS

Official title: Continuous Glucose Monitoring in Polycystic Ovarian Syndrome

Run by The Cleveland Clinic · NCT07392476 · Data updated 2026-11-12

This study tests how blood sugar changes over time in adults with PCOS using a continuous glucose monitor.

Quick facts

Study typeObservational
Ages18 Years to 45 Years
SexAll
Enrollment40 (estimated)
SponsorThe Cleveland Clinic
Academic / other
Locations1 site (Cleveland, Ohio)
StatusRecruiting
StartedDecember 24, 2025
Main results expectedDecember 31, 2026
Study endsAugust 15, 2027
Registry record updatedOctober 6, 2026
Trial IDNCT07392476 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults 18-45 with PCOS (per Rotterdam criteria) and BMI over 25 kg/m2, who own a Stelo-compatible phone and are not using glucose-lowering or weight-loss medications.

Probably not a fit

Individuals on medications that affect glucose or weight, or those with insulin use, may not directly benefit from participation.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study uses a Dexcom Stelo glucose sensor to track glucose levels in adults aged 18-45 with PCOS over about six months. Participants will wear the CGM at specified times, have two small blood draws, and complete body composition measurements and questionnaires at set visits. The study aims to characterize glycemic patterns in PCOS and how they relate to body composition and self-reported data. Participation will involve in-clinic visits and remote monitoring using a compatible phone. No experimental therapies are administered as part of this study.

Why it matters

Potential benefit: If successful, findings may improve understanding of blood sugar control in PCOS and inform personalized management strategies.

How similar studies have gone: Prior observational work with CGM in metabolic conditions has yielded actionable insights, but direct results in PCOS remain exploratory.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria

1. Adult 18-45 years old
2. Diagnosis of PCOS by usual clinical method such as by Rotterdam criteria
3. BMI \>25 kg/m2

Exclusion Criteria

1. Currently on medications that can improve glucose levels such as metformin and glucagon like receptor 1 agonists (GLP1RA) or on medications taken for the purpose of weight loss such as phentermine, topiramate, and bupropion.
2. Previously intake of above-mentioned medications and less than 3 months since last intake of metformin or weight loss medications, and less than 6 months since last intake of GLP1RA
3. Currently on insulin
4. Does not have Stelo-compatible phone
5. Fasting glucose \>100 mg/dL (because that is the cutoff for prediabetes) (either labs taken within a week after first visit or within 3 months before start of study
6. HbA1c \> 5.7% (because this is the cutoff for prediabetes) (either labs taken after screening visit or within 3 months before start of study)
7. History of anorexia or bulimia
8. Current or previous CGM use
9. Use of oral contraceptives at time of enrolment
10. Intent to become pregnant within 6 months (will need to terminate study if gets pregnant as glucose readings will be affected)
11. Menopausal women

Where it's running

  • Cleveland Clinic
    Cleveland, Ohio, United States
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.